<DOC>
	<DOCNO>NCT02954510</DOCNO>
	<brief_summary>There current alternative diagnostic contrast-requiring imaging patient eGFR &lt; 30mL/min due association gadolinium-based imaging modality nephrogenic systemic fibrosis iodinate contrast-induced kidney injury . Ferumoxytol-enhanced imaging may offer alternative approach .</brief_summary>
	<brief_title>Ferumoxytol Magnetic Resonance Imaging Patients With Severe Kidney Disease</brief_title>
	<detailed_description>1 . Identify resolution coronary artery visualize use ferumoxytol-enhanced cardiac magnetic resonance image non-morbidly obese patient prior regional cardiac ischemia localize stress-induced echocardiography technetium-based myocardial perfusion imaging . 2 . Use ferumoxytol-enhanced cardiac MRI quantify location length lesion leave right coronary artery branch artery derive leave right coronary artery . 3 . Identify resolution peripheral vasculature visualize use ferumoxytol-enhanced MR angiography venography patient clinical finding consistent peripheral vascular disease . 4 . Use ferumoxytol-enhanced MR angiography venography quantify location length lesion femoral artery branch vessel .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Ferrosoferric Oxide</mesh_term>
	<criteria>Gender * FDAAA •Both : female male participant study Age Limits Minimum Age : 18 year old Maximum Age : 85 year old Accepts Healthy Volunteers ? No . Eligibility Criteria glomerular filtration rate &lt; 30ml/min/1.73m2 glomerular filtration rate &gt; 29ml/min/1.73m2 Study Population Description Patients chronic kidney disease clinic dialysis unit Sampling Method •NonProbability Sample : invitation volunteer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>